A growing number of research grants and projects by various research organizations will help to boost global exosomes market in the forecasted period. Exosomes play a significant role in facilitating cell-to-cell communication in the cancer prognosis. It helps to suppress the immune function by inducing apoptosis of activated cytotoxic T cells, which allow tumor progression in the human body. Also, exosomes stimulate the angiogenesis and migration leading to metastasis. In Addition, it triggers apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Increasing occurrence of cancer, technological advancements in exosomes isolation and analytical procedures are the key drivers of global exosomes market.
|High Growth Market||Asia- Pacific|
|Unit||Value (USD Million)|
|Key Companies Profiled||Fujifilm (Japan), Thermo Fisher Scientific, Inc. (United States), Danaher (United States), Lonza (Switzerland), Illumina, Inc. (United States), Qiagen (Germany), Takara Bio Company (Japan), Malvern Instruments Ltd. (United Kingdom), Miltenyi Biotec (Germany) and Aethlon Medical, Inc. (United States)|
According to AMA, the market for Exosomes is expected to register a CAGR of 16.8% during the forecast period to 2027. This growth is primarily driven by High Global Prevalence of Cancer and Increasing Interest in Exosome-Based Procedures.
Globally, a noticeable market trend is evident Rising Expenditure for Life Science Research and Developments
. The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Fujifilm (Japan), Thermo Fisher Scientific, Inc. (United States), Danaher (United States), Lonza (Switzerland), Illumina, Inc. (United States), Qiagen (Germany), Takara Bio Company (Japan), Malvern Instruments Ltd. (United Kingdom), Miltenyi Biotec (Germany) and Aethlon Medical, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On 13th July 2018, Exosomics Siena S.p.A., a pioneer and world leader in exosome-based diagnostics have launched of its first proprietary liquid biopsy solutions, SeleCTEV™ DNA and SortEV™ RNA, for the selective isolation of tumor-derived nucleic acids from complex biofluids such as plasma or serum.
On 25th June 2018, Bio-Techne Corporation has acquired Exosome Diagnostics, Inc. the deal was established for 250 million dollars in cash plus contingent consideration of up to 325 million dollars due upon the achievement of certain future milestones.
- High Global Prevalence of Cancer
- Increasing Interest in Exosome-Based Procedures
- Rising Expenditure for Life Science Research and Developments
- Growing Number of Advanced Applications of Exosomes
- Dearth of Skilled Professionals
High Adoption in Untapped Emerging Countries and Huge Opportunity Due to Personalized Medicine
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Exosomes Study Sheds Light on
The Exosomes Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Exosomes industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Exosomes industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.